BR112013008749A2 - análogos de ciclosporina - Google Patents

análogos de ciclosporina

Info

Publication number
BR112013008749A2
BR112013008749A2 BR112013008749A BR112013008749A BR112013008749A2 BR 112013008749 A2 BR112013008749 A2 BR 112013008749A2 BR 112013008749 A BR112013008749 A BR 112013008749A BR 112013008749 A BR112013008749 A BR 112013008749A BR 112013008749 A2 BR112013008749 A2 BR 112013008749A2
Authority
BR
Brazil
Prior art keywords
cyclosporine analogs
cyclosporine
analogs
conditions
methods
Prior art date
Application number
BR112013008749A
Other languages
English (en)
Inventor
S Schaumburg Christopher
Arthur Scowen David
E Garst Michael
E Stern Michael
Robert Carling William
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BR112013008749A2 publication Critical patent/BR112013008749A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Abstract

análogos de ciclosporina. a presente invneção refere-se a análogos de ciclosporina, composições farmacêuticas contendo os mesmos e métodos para sua utilização no tratamento de olho seco e de outras condições.
BR112013008749A 2010-10-12 2011-10-11 análogos de ciclosporina BR112013008749A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39245110P 2010-10-12 2010-10-12
PCT/US2011/055788 WO2012051193A1 (en) 2010-10-12 2011-10-11 Cyclosporin analogs

Publications (1)

Publication Number Publication Date
BR112013008749A2 true BR112013008749A2 (pt) 2019-09-24

Family

ID=44883796

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013008749A BR112013008749A2 (pt) 2010-10-12 2011-10-11 análogos de ciclosporina

Country Status (12)

Country Link
US (2) US9175042B2 (pt)
EP (1) EP2627663B1 (pt)
JP (1) JP5805773B2 (pt)
KR (1) KR20140026328A (pt)
CN (1) CN103261212A (pt)
AU (1) AU2011316689B2 (pt)
BR (1) BR112013008749A2 (pt)
CA (1) CA2814191A1 (pt)
IL (1) IL225616A0 (pt)
MX (1) MX2013004062A (pt)
RU (1) RU2013120927A (pt)
WO (1) WO2012051193A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100305047A1 (en) * 2009-05-27 2010-12-02 Allergan, Inc. Cyclosporin derivatives for enhancing the growth of hair
MY165152A (en) * 2010-12-15 2018-02-28 Contravir Pharmaceuticals Inc Cyclosporine analogue molecules modified at amino acid 1 and 3
EP2855508B1 (en) 2012-06-01 2018-02-14 Allergan, Inc. Cyclosporin a analogs
EP2964268A1 (en) 2013-03-08 2016-01-13 Allergan, Inc. Antibiotic conjugates
TW201639873A (zh) 2015-01-08 2016-11-16 歐樂根公司 Ｍｅｂｍｔ側鏈已環化之環孢菌素衍生物
US20180164221A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
JP2020513280A (ja) 2016-12-14 2020-05-14 プロジェニティ， インコーポレイテッド 消化管疾病の免疫抑制剤による治療
WO2019246312A1 (en) 2018-06-20 2019-12-26 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator
CN115028681B (zh) * 2022-08-11 2022-11-15 中国科学院微生物研究所 一种降解亲环素a的嵌合体化合物及其制备方法与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757522B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2762843B1 (fr) 1997-04-30 1999-12-10 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2772768B1 (fr) * 1997-12-19 2000-01-14 Rhone Poulenc Rorer Sa Nouveau procede de preparation de derives de cyclosporine
PT1086124E (pt) 1998-06-12 2004-04-30 Chem Ag C Ciclosporinas novas
US6254860B1 (en) 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
CN100478025C (zh) * 2005-03-25 2009-04-15 中国科学院上海药物研究所 一种环孢菌素a眼用微乳制剂及其制备方法
WO2007136759A2 (en) * 2006-05-19 2007-11-29 Scynexis, Inc. Method for the treatment and prevention of ocular disorders
BRPI0811538A2 (pt) 2007-05-04 2015-08-11 Allergan Inc Uso de ciclosporinas no tratamento de pacientes com lentes intraoculares.
BRPI0915552A2 (pt) 2008-07-10 2017-06-20 Allergan Inc derivados de ciclosporina, seu uso e sua composição farmacêutica
CN103153329A (zh) * 2010-07-16 2013-06-12 美国科技环球有限公司 新颖的环孢霉素a衍生物在病毒感染的治疗和预防中的应用
US9573978B2 (en) * 2010-08-12 2017-02-21 S&T Global, Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
WO2012051194A1 (en) 2010-10-12 2012-04-19 Allergan, Inc. Cyclosporin analogs
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
CA2819608C (en) * 2010-12-03 2020-03-31 S&T Global Inc. Novel cyclosporin derivatives for the treatment and prevention of a viral infection

Also Published As

Publication number Publication date
US20160022765A1 (en) 2016-01-28
AU2011316689A1 (en) 2013-05-02
US9175042B2 (en) 2015-11-03
EP2627663B1 (en) 2018-02-21
RU2013120927A (ru) 2014-11-20
MX2013004062A (es) 2013-07-22
US9561259B2 (en) 2017-02-07
CA2814191A1 (en) 2012-04-19
JP5805773B2 (ja) 2015-11-10
JP2013544786A (ja) 2013-12-19
IL225616A0 (en) 2013-06-27
AU2011316689B2 (en) 2016-07-14
KR20140026328A (ko) 2014-03-05
WO2012051193A1 (en) 2012-04-19
EP2627663A1 (en) 2013-08-21
US20120135939A1 (en) 2012-05-31
CN103261212A (zh) 2013-08-21

Similar Documents

Publication Publication Date Title
BR112013008749A2 (pt) análogos de ciclosporina
BR112015001101A2 (pt) formas cristalinas de um inibidor de prolil hidroxilase
CO7151535A2 (es) Evento de maiz mon 87411
EA201401077A1 (ru) Биспецифические антитела к человеческому tweak и человеческому il17 и их применения
BR112015022191A8 (pt) compostos heteroarila e usos dos mesmos
UY35210A (es) Inhibidores de autotaxina
UY34811A (es) Compuestos y composiciones para inhibir la actividad de la abl1, abl2 y bcr-abl1
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
UY33917A (es) ?composiciones para recubrimiento que comprenden submicropartículas que comprenden carbonato de calcio, proceso para prepararlas, y uso de las submicropartículas?.
BR112012024312A2 (pt) anticorpos biespecíficos
UY34697A (es) Métodos para preparar análogos de nucleótidos
UY34885A (es) Proteínas de unión anti-mesotelina
BR112017007123A2 (pt) derivados de tetrahidroisoquinolina
BR112014005744A2 (pt) composições de peptídeo glucagon-like-2 e métodos para sua produção e utilização
MX2013004061A (es) Analogos de ciclosporina.
CL2013001947A1 (es) Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona.
UY34210A (es) Composiciones, métodos y sistemas para la micropropagación de plantas
WO2012129341A3 (en) Disease detection in plants
BR112014017673A8 (pt) Compostos de sulfonamida tricíclicos e métodos para fazer e usar os mesmos
BR112014025041B8 (pt) Composição farmacêutica
MY173521A (en) Trpv4 antagonists
EA201591451A1 (ru) Модуляторы flap
BR112015014453A2 (pt) produtos de cuidado oral compreendendo cloreto de zinco tetrabásico e trimetilglicina
EA201491609A1 (ru) Модуляторы x рецепторов печени
BR112014005935A2 (pt) derivados de anilina, sua preparação e sua aplicação terapêutica

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.